| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/13/2004 | WO2003003014A9 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 05/13/2004 | WO2002016440A9 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 05/13/2004 | WO1992004464A3 Monoclonal antibodies against tenascin |
| 05/13/2004 | US20040093627 Methods |
| 05/13/2004 | US20040093626 Screening modulators of g-protein couple receptors to identify appetite control agent for treatment of physiological eating disorders and obesity |
| 05/13/2004 | US20040093622 Preparing transgenic rodent expressing genetically engineered immunoglobulins for treatment hypercholesterolemia, atherosclerosis, cystic fibrosis and muscular dystrophy |
| 05/13/2004 | US20040093621 Trangenic cells which generate immunoglobulins for treatment of cancer and immunological diseases |
| 05/13/2004 | US20040092723 Immunoglobulin fusion for diagnosis and treatment of cancer and viral diseases |
| 05/13/2004 | US20040092722 Preparing immunoglobulin for diagnosis and treatment of cardiovascular disorders |
| 05/13/2004 | US20040092721 Ligand comprising monoclonal antibody for treatment of tumors and prevention of tumor metastasis; antitumor agents |
| 05/13/2004 | US20040092719 Using hydrophobic interaction chromatography to separate and isolated heavy chain modified immunoglobulins |
| 05/13/2004 | US20040092718 Use of a CD28 binding substance for making a pharmaceutical composition |
| 05/13/2004 | US20040092714 Comprises osteoclast associated receptors (OSCAR) for the identifying modulators for treatment of bone disorders |
| 05/13/2004 | US20040092712 Monoclonal antibody which binds toll-like receptor (TLR) for use in identifying modulators for treatment and prevention of sepsis |
| 05/13/2004 | US20040092450 Polypeptide that has mitogenic activity; treating fibroproliferative disorders |
| 05/13/2004 | US20040092007 Allelic growth differentiation factor-9b (GDF-9B) for treatment annd prevention of sex disorders; in vitro fertilization; artificial insemination; veterinary medicine |
| 05/13/2004 | US20040091974 Anti-hla-dr antibody |
| 05/13/2004 | US20040091973 Process for selecting anti-angiognesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use |
| 05/13/2004 | US20040091972 Membrane protein for diagnosis, prevention and treatment cell proliferative disorders |
| 05/13/2004 | US20040091959 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; diagnosis cancer |
| 05/13/2004 | US20040091957 Preparing deglycosylated immunoglobulin using proteolytic cleavage for use in medical diagnostics, chemical assays, drug screening and proteomics |
| 05/13/2004 | US20040091907 GEF-H1b: biomarkers, complexes assays and therapeutic uses thereof |
| 05/13/2004 | US20040091895 Human sprouty-4 polypeptide |
| 05/13/2004 | US20040091894 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 05/13/2004 | US20040091851 HCV peptide compositions |
| 05/13/2004 | US20040091498 Defensins: use as antiviral agents |
| 05/13/2004 | US20040091496 Vaccine |
| 05/13/2004 | US20040091494 P. aeruginosa mucoid exopolysaccharide specific binding peptides |
| 05/13/2004 | US20040091491 An immune response modifier portion such as a Toll-like receptor or an imidazoquinoline compound paired with an antigenic portion; use of toll-like receptor improves immune response over conventional immune response modifiers |
| 05/13/2004 | US20040091490 Where the antibody is conjugated to a polymer such as polyethylene glycol and contains a succinimide linker, and buffer maintains an acidic pH of 3.5 to 6; storage stability; anti-TNF-alpha antibodies for inflammatory disease treatment |
| 05/13/2004 | US20040091489 Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point |
| 05/13/2004 | US20040091488 Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof |
| 05/13/2004 | US20040091486 EphA2 agonistic monoclonal antibodies and methods of use thereof |
| 05/13/2004 | US20040091485 Humanised antibodies to the epidermal growth factor receptor |
| 05/13/2004 | US20040091484 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/13/2004 | US20040091482 Humanized collagen antibodies and related methods |
| 05/13/2004 | US20040091481 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 05/13/2004 | US20040091480 Anti-fibroblast growth factor-8 monoclonal antibody |
| 05/13/2004 | US20040091478 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding |
| 05/13/2004 | US20040091476 Enhance or suppress T-cell activation and proliferation |
| 05/13/2004 | US20040091475 Degraded tpo agonist antibody |
| 05/13/2004 | US20040091474 Degradation and detection of TSE infectivity |
| 05/13/2004 | US20040091473 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 05/13/2004 | DE10249860A1 Use of neuroglobin for producing a medicament for treating diseases of retina, or for producing a diagnostic agent for diagnosing diseases of the retina |
| 05/13/2004 | CA2504178A1 Methods and kits for diagnosing tumorigenicity |
| 05/13/2004 | CA2503888A1 Chimeric cytoplasmic signalling molecules |
| 05/13/2004 | CA2503763A1 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 05/13/2004 | CA2503697A1 Trimeric binding proteins for trimeric cytokines |
| 05/13/2004 | CA2502088A1 Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis |
| 05/13/2004 | CA2485342A1 Humanized antibodies against the venezuelan equine encephalitis virus |
| 05/12/2004 | EP1418235A2 Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 05/12/2004 | EP1418234A1 Human monoclonal antibodies against oxidized ldl receptor and medicinal use thereof |
| 05/12/2004 | EP1418184A1 Recombinant fusion protein consisting of the p40 and p35 subunits of IL-12 and a ScFv and use thereof |
| 05/12/2004 | EP1418183A1 Cystic fibrosis gene |
| 05/12/2004 | EP1417342A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 05/12/2004 | EP1417340A2 Method for the detection of a polymorphism in cpb2 |
| 05/12/2004 | EP1417338A1 Genes and snps associated with eating disorders |
| 05/12/2004 | EP1417328A2 Invasion complex and methods of targeting |
| 05/12/2004 | EP1417316A2 Expression of modified antibodies in avian cells |
| 05/12/2004 | EP1417314A2 Novel amylases and uses thereof |
| 05/12/2004 | EP1417234A2 Recombinant anti-plasmodium falciparum antibodies |
| 05/12/2004 | EP1417233A2 Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof |
| 05/12/2004 | EP1417232A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 05/12/2004 | EP1417231A2 Modified human thymic stromal lymphopoietin |
| 05/12/2004 | EP1417228A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417227A2 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417224A2 Secreted proteins |
| 05/12/2004 | EP1417222A1 Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralzing annti-p17 antibodies which specifically recognize said neutralizing epitope |
| 05/12/2004 | EP1417221A2 Mimotope of neisseria meningitidis lipooligosaccharide and vaccines containing the same |
| 05/12/2004 | EP1416965A2 Assay method for alzheimer's disease |
| 05/12/2004 | EP1416963A1 Treating, preventing, or detecting angiogenesis with an anti-a2b antibody |
| 05/12/2004 | EP1416962A2 Method of improving cognitive function |
| 05/12/2004 | EP1416961A1 Composition and method for the treatment of disease |
| 05/12/2004 | EP1416960A1 Vegfr-1 antibodies to treat breast cancer |
| 05/12/2004 | EP1416957A2 Treatment of immune disorders and b cell disorders |
| 05/12/2004 | EP1416954A1 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 05/12/2004 | EP1416945A1 Improved heteropolymer complexes and methods for their use |
| 05/12/2004 | EP1217891A4 Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family |
| 05/12/2004 | EP1112499B1 Method for detecting or quantifying basophils and eosinophils |
| 05/12/2004 | EP0862444B1 Treatment of dilated cardiomyopathy by removal of autoantibodies |
| 05/12/2004 | EP0833911B1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof |
| 05/12/2004 | EP0826005B1 Use of avian, vitellin antibodies directed against hiv antigens for the manufacture of pharmaceutical preparations |
| 05/12/2004 | EP0815240B1 Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 05/12/2004 | EP0804577B1 cDNA ENCODING A BMP TYPE II RECEPTOR |
| 05/12/2004 | EP0607425B1 Epstein-barr virus peptides and antibodies against these peptides |
| 05/12/2004 | CN1496370A Isolated GUM operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof |
| 05/12/2004 | CN1495258A Human tissue inhibitor of metalloprotease-4 |
| 05/12/2004 | CN1495199A Monoclonal antibody for identifying platelet membrane glycoprotein and its application for curing thrombus |
| 05/12/2004 | CN1495196A Purification of human myocardium troponin I and preparation method of its monoclonal anti-body |
| 05/12/2004 | CN1495193A Recombinant humanized anti-hepatitis B surface antigen (HBs Ag) Fab antibody and its preparaticon method |
| 05/12/2004 | CN1149290C Novel Human Lysozyme gene, its encodling polypeptide and the method for preparing them |
| 05/12/2004 | CN1149286C Ligand polypeptides for the G-protein-coupled recetpor protein, their production and use |
| 05/12/2004 | CN1149224C Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 05/12/2004 | CN1149100C Room temperature storable immunoglobulin preparation for intravenous injection |
| 05/11/2004 | US6734293 Novel extracts, proteins, and complexes that improve the polymerization activity of nucleic acid polymerases |
| 05/11/2004 | US6734289 Gastrokines and derived peptides including inhibitors |
| 05/11/2004 | US6734288 Antibodies against a secreted polypeptide that stimulates release of proteoglycans from cartilage |
| 05/11/2004 | US6734287 Specific binding proteins for treating canine allergy |
| 05/11/2004 | US6734286 Interleukin-5 specific recombinant antibodies |
| 05/11/2004 | US6734284 Exhibits high affinity for the gfr alpha 3- ret receptor complex and unique subregions in its amino acid sequence |